Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit.

Drolz A, Horvatits T, Roedl K, Rutter K, Staufer K, Haider DG, Zauner C, Heinz G, Schellongowski P, Kluge S, Trauner M, Fuhrmann V.

Ann Intensive Care. 2016 Dec;6(1):61. doi: 10.1186/s13613-016-0162-4.

2.

Prognostic factors of in-hospital mortality in all comers with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Kiatchoosakun S, Wongwipaporn C, Pussadhamma B.

Heart Asia. 2016 Jun 14;8(2):13-7. doi: 10.1136/heartasia-2015-010715.

3.

Influence of heart failure on the prognosis of patients with acute myocardial infarction in southwestern China.

Deng F, Xia Y, Fu M, Hu Y, Jia F, Rahardjo Y, Duan Y, He L, Chang J.

Exp Ther Med. 2016 Jun;11(6):2127-2138.

4.

Decade-Long Trends (2001-2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction.

Goldberg RJ, Makam RC, Yarzebski J, McManus DD, Lessard D, Gore JM.

Circ Cardiovasc Qual Outcomes. 2016 Mar;9(2):117-25. doi: 10.1161/CIRCOUTCOMES.115.002359.

PMID:
26884615
5.

Relation of Atrial Fibrillation in Acute Myocardial Infarction to In-Hospital Complications and Early Hospital Readmission.

Kundu A, O'Day K, Shaikh AY, Lessard DM, Saczynski JS, Yarzebski J, Darling CE, Thabet R, Akhter MW, Floyd KC, Goldberg RJ, McManus DD.

Am J Cardiol. 2016 Apr 15;117(8):1213-8. doi: 10.1016/j.amjcard.2016.01.012.

PMID:
26874548
6.

Intra-Aortic Balloon Pump Counterpulsation during Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction and Cardiogenic Shock: Insights from the British Columbia Cardiac Registry.

Iqbal MB, Robinson SD, Ding L, Fung A, Aymong E, Chan AW, Hodge S, Della Siega A, Nadra IJ; British Columbia Cardiac Registry Investigators..

PLoS One. 2016 Feb 12;11(2):e0148931. doi: 10.1371/journal.pone.0148931.

7.

In-Hospital Outcome of Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction: Results from Royal Hospital Percutaneous Coronary Intervention Registry, Oman.

Islam MS, Panduranga P, Al-Mukhaini M, Al-Riyami A, El-Deeb M, Rahman SA, Al-Riyami MB.

Oman Med J. 2016 Jan;31(1):46-51. doi: 10.5001/omj.2016.09.

8.

Trends of 28 days case fatality rate after first acute myocardial infarction in Isfahan, Iran, from 2000 to 2009.

Mohammadian M, Hosseini S, Sadeghi M, Sarrafzadegan N, Salehiniya H, Roohafza H, Khazaei S, Mohammadian-Hafshejani A.

ARYA Atheroscler. 2015 Jul;11(4):233-43.

9.

Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.

Fuernau G, Pöss J, Denks D, Desch S, Heine GH, Eitel I, Seiler S, de Waha S, Ewen S, Link A, Schuler G, Adams V, Böhm M, Thiele H.

Crit Care. 2014 Dec 21;18(6):713. doi: 10.1186/s13054-014-0713-8.

10.

Challenges of ascertaining national trends in the incidence of coronary heart disease in the United States.

Ford ES, Roger VL, Dunlay SM, Go AS, Rosamond WD.

J Am Heart Assoc. 2014 Dec 3;3(6):e001097. doi: 10.1161/JAHA.114.001097. Review. No abstract available.

11.

Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention.

Victor SM, Gnanaraj A, S V, Deshmukh R, Kandasamy M, Janakiraman E, Pandurangi UM, Latchumanadhas K, Abraham G, Mullasari AS.

Indian Heart J. 2014 Sep-Oct;66(5):517-24. doi: 10.1016/j.ihj.2014.05.025.

12.

Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine.

Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke R, Mebazaa A, Pinsky MR, Teboul JL, Vincent JL, Rhodes A.

Intensive Care Med. 2014 Dec;40(12):1795-815. doi: 10.1007/s00134-014-3525-z.

14.

Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States.

Kolte D, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, Jain D, Gotsis W, Ahmed A, Frishman WH, Fonarow GC.

J Am Heart Assoc. 2014 Jan 13;3(1):e000590. doi: 10.1161/JAHA.113.000590.

15.

FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock.

Pöss J, Mahfoud F, Seiler S, Heine GH, Fliser D, Böhm M, Link A.

Eur Heart J Acute Cardiovasc Care. 2013 Sep;2(3):211-8. doi: 10.1177/2048872613494025.

16.

Trends in atrial fibrillation in patients hospitalized with an acute coronary syndrome.

McManus DD, Huang W, Domakonda KV, Ward J, Saczysnki JS, Gore JM, Goldberg RJ.

Am J Med. 2012 Nov;125(11):1076-84. doi: 10.1016/j.amjmed.2012.05.024.

17.

Percutaneous coronary intervention in cardiogenic shock complicating acute ST-elevation myocardial infarction-a single centre experience.

Subban V, Gnanaraj A, Gomathi B, Janakiraman E, Pandurangi U, Kalidoss L, Ajit SM.

Indian Heart J. 2012 Mar-Apr;64(2):152-8. doi: 10.1016/S0019-4832(12)60052-2.

18.

Long-term trends in short-term outcomes in acute myocardial infarction.

Nguyen HL, Saczynski JS, Gore JM, Waring ME, Lessard D, Yarzebski J, Reed G, Spencer FA, Li SX, Goldberg RJ.

Am J Med. 2011 Oct;124(10):939-46. doi: 10.1016/j.amjmed.2011.05.023.

19.

Rapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarction.

Ramanathan K, Farkouh ME, Cosmi JE, French JK, Harkness SM, Džavík V, Sleeper LA, Hochman JS.

Am Heart J. 2011 Aug;162(2):268-75. doi: 10.1016/j.ahj.2011.04.025.

20.

Primary Percutaneous Coronary Intervention (PPCI) in acute myocardial infarction complicated with cardiogenic shock in a newly emerging cardiac center in Nepal.

Maskey A, Regmi SR, Dubey L, Bhatt Y, Malla R, Limbu YR, Sharma D, Bahadur M.

J Res Med Sci. 2009 Mar;14(2):123-7.

Items per page

Supplemental Content

Support Center